InsiderClue
Insiders · Profile

Lebwohl David

EVP, Chief Medical Officer at Intellia Therapeutics. Filing since 9 Aug 2021. CIK 0001810882

Company
Date
Role
Action
Shares
Amount
Of holding
NTLA Intellia Therapeutics, Inc.
5 Jan 2026
EVP, Chief Medical Officer
Sold at will
11,903
$109.63K
8.9%
NTLA Intellia Therapeutics, Inc.
3 Jan 2025
EVP, Chief Medical Officer
Sold at will
9,557
$116.40K
9.8%
NTLA Intellia Therapeutics, Inc.
3 Jan 2024
EVP, Chief Medical Officer
Sold at will
5,843
$172.13K
9.7%
NTLA Intellia Therapeutics, Inc.
4 Jan 2023
EVP, Chief Medical Officer
Sold, plan not stated
2,574
$95.78K
9.1%
NTLA Intellia Therapeutics, Inc.
1 Jan 2022
EVP, Chief Medical Officer
Sold, plan not stated
1,051
$117.96K
8.8%
NTLA Intellia Therapeutics, Inc.
5 Nov 2021
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$318.53K
21.6%
NTLA Intellia Therapeutics, Inc.
14 Oct 2021
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$308.25K
21.6%
NTLA Intellia Therapeutics, Inc.
21 Sep 2021
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$359.54K
75.2%
NTLA Intellia Therapeutics, Inc.
30 Aug 2021
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$379.30K
75.2%
NTLA Intellia Therapeutics, Inc.
9 Aug 2021
EVP, Chief Medical Officer
Sold, plan not stated
2,400
$393.72K
75.2%
10 decisions on file.